Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14594-6 Amitriptyline+Nortriptyline PrThr Gast fld Pt Ord     ACTIVE Amitriptyline+Nortriptyline [Presence] in Gastric fluid   MIN DefinitionDescription                   DRUG/TOX   14594-6         Both       0 Amitrip+Nor Gast Ql           Amit; Amitrip; Amitrip+Nor; Amitriptylene; Amitriptyline metabolite; Amitriptyln; Aventyl; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; GAST; Gastric contents; Gastric fluid; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trepiline; Tryptanol; Tryptizol 2.56 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14595-3 Amitriptyline+Nortriptyline PrThr Ser/Plas Pt Ord     ACTIVE Amitriptyline+Nortriptyline [Presence] in Serum or Plasma   MIN DefinitionDescription                   DRUG/TOX   14595-3         Both       0 Amitrip+Nor SerPl Ql           Amit; Amitrip; Amitrip+Nor; Amitriptylene; Amitriptyline metabolite; Amitriptyln; Aventyl; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Pl; Plasma; Plsm; Point in time; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Trepiline; Tryptanol; Tryptizol 2.73 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14596-1 Amitriptyline+Nortriptyline PrThr Urine Pt Ord     ACTIVE Amitriptyline+Nortriptyline [Presence] in Urine   MIN DefinitionDescription                   DRUG/TOX   14596-1         Both       0 Amitrip+Nor Ur Ql           Amit; Amitrip; Amitrip+Nor; Amitriptylene; Amitriptyline metabolite; Amitriptyln; Aventyl; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Nortrip; Nortriptylene; Nortriptyln; Ordinal; Pamelor; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Trepiline; Tryptanol; Tryptizol; UA; UR; Urn 2.73 1.0k                     The Property has been changed from ACnc to reflect the new model for ordinal terms where results are based on a cut-off value.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14597-9 Amitriptyline SCnc Ser/Plas Pt Qn     ACTIVE Amitriptyline [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   14597-9         Both       0 Amitrip SerPl-sCnc       Y   Amit; Amitrip; Amitriptylene; Amitriptyln; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trepiline; Tryptanol; Tryptizol 2.34 1.0k               nmol/L       0
14598-7 Amitriptyline+Nortriptyline SCnc Ser/Plas Pt Qn     ACTIVE Amitriptyline+Nortriptyline [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14598-7         Both       0 Amitrip+Nor SerPl-sCnc       Y   Amit; Amitrip; Amitrip+Nor; Amitriptylene; Amitriptyline metabolite; Amitriptyln; Aventyl; DRUG/TOXICOLOGY; Drugs; Elatrol; Elavil; Endep; Level; Nortrip; Nortriptylene; Nortriptyln; Pamelor; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trepiline; Tryptanol; Tryptizol 2.34 1.0k               umol/L       0
14599-5 Ammonium PrThr Calculus Pt Ord     ACTIVE Ammonium [Presence] in Stone   MIN DefinitionDescription                   CHEM   14599-5         Both       0 Ammonium Stone Ql           Amm; Ammon; Calc; Calculi; Chemistry; NH4; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Stn; Stone; Stones 2.56 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
146-1 Cefuroxime.parenteral Susc Isolate Pt OrdQn Agar diffusion   ACTIVE Cefuroxime Parenteral [Susceptibility] by Disk diffusion (KB)   MIN DefinitionDescription                   ABXBACT   146-1   Agar diffusion     Observation       0 Cefuroxime Parenter Islt KB           ANTIBIOTIC SUSCEPTIBILITIES; AST; c308; C33; Ceftin; Cefuroxime Axetil; Cefuroxime Parenter; Cefuroxime Sodium; Curoxim; Disk diffusion; ID; Infectious Disease; InfectiousDisease; Islt; Isol; KB; Kefurox; Kirby-bauer; Point in time; Random; Sus; Suscept; Susceptibilities; Susceptibility; Susceptibilty; Ultroxim; Zinacef 2.73 1                       0
1460-5 Cobalamins^post dose cyanocobalamin MRat Urine 24H Qn     ACTIVE Cobalamin (Vitamin B12) [Mass/time] in 24 hour Urine --post dose cyanocobalamin   MIN DefinitionDescription     mg/24 H             CHAL   1460-5         Observation       0 Vit B12 p B12 24h Ur-mRate       Y   1 day; 24 hours; 24HR; After; c133; C721; Cbl; CHEMISTRY.CHALLENGE TESTING; CN-Cbl; Cobalamin; Mass rate; mRate; p B12; p dose; PST; QNT; Quan; Quant; Quantitative; Schilling test; Schillings test; UA; UR; Urn; Vit B12; Vitamin B12 2.42 1               mg/(24.h)       0
14600-1 Amoxapine SCnc Ser/Plas Pt Qn     ACTIVE Amoxapine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14600-1         Both       0 Amoxapine SerPl-sCnc       Y   Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Level; Moxadil; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14601-9 Amoxapine+8-Hydroxyamoxapine SCnc Ser/Plas Pt Qn     ACTIVE Amoxapine+8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14601-9         Both       0 Amoxapine+8OH-Amox SerPl-sCnc       Y   8-Hydroxy amoxapine; 8OH-Amoxapine; Amox; Amoxapine metabolite; Amoxapine+8OH-Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Level; Moxadil; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.4 1.0k               umol/L       0
14602-7 Amoxapine+8-Hydroxyamoxapine SCnc Ser/Plas Pt Qn     DEPRECATED Deprecated Amoxapine+8-Hydroxyamoxapine [Molecules/volume] in Serum or Plasma   DEL DefinitionDescription     umol/L             DRUG/TOX   14602-7                 0 Deprecated Amoxapine+8OH-Amox SerPl-sCnc           8-Hydroxy amoxapine; 8OH-Amoxapine; Amox; Amoxapine metabolite; Amoxapine+8OH-Amox; Asendin; Defanyl; Demolox; DRUG/TOXICOLOGY; Drugs; Level; Moxadil; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.36 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14603-5 Androstenedione SCnc Ser/Plas Pt Qn     ACTIVE Androstenedione [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             CHEM   14603-5         Both       0 Androst SerPl-sCnc       Y   Chemistry; gamma-4-Androstenedione; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               nmol/L       0
14604-3 Blood group antibodies Prid Ser/Plas^BPU Pt Nom     ACTIVE Blood group antibodies identified in Serum or Plasma from Blood product unit   NAM DefinitionDescription                   BLDBK   14604-3         Observation       0 Blood group antibodies SerPl BPU           BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPl^bpu; SerPlas; Serum; Serum or plasma; SR 2.79 1.0k                     Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; 0
14605-0 Blood group antibodies Prid Ser/Plas^Donor Pt Nom     ACTIVE Blood group antibodies identified in Serum or Plasma from Donor   NAM DefinitionDescription                   BLDBK   14605-0         Observation       0 Blood group antibodies SerPl Donr           BLOOD BANK; Donr; Identity or presence; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 1.0k                     Release 2.79: COMPONENT: Triggered by the coll w SCT:The understanding is that the word "identified" refers to the property "PRID", its presence in the component is redundant to the property. Therefore it is better to remove "identified" from the component.; 0
14606-8 Blood group antibody PrThr Ser/Plas Pt Ord Blood group antibody screen.Prewarmed   ACTIVE Blood group antibody screen [Presence] in Serum or Plasma by Prewarmed   NAM DefinitionDescription                   BLDBK   14606-8   Blood group antibody screen.Prewarmed     Observation       0 Bld gp Ab Scn SerPl Ql Pwarm           Ab; Bld gp Ab Scn; BLOOD BANK; Ordinal; Pl; Plasma; Plsm; Point in time; PR; Pwarm; Ql; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.79 1.0k                     Release 2.79: COMPONENT: Triggered by Coll w SCT: Screen should be omitted from Component. It should be in Method.; Previous Releases: The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14607-6 Nuclear Ab PrThr Body fld Pt Ord     ACTIVE Nuclear Ab [Presence] in Body fluid   MIN DefinitionDescription                   SERO   14607-6         Both       0 ANA Fld Ql           ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Fl; Fld; FLU; Fluid; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology 2.73 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14608-4 Nuclear Ab PrThr Plr fld Pt Ord     ACTIVE Nuclear Ab [Presence] in Pleural fluid   MIN DefinitionDescription                   SERO   14608-4         Both       0 ANA Plr Ql           ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Lung; NA; Nuc; Ordinal; Pleural; Pleural fluid; Point in time; PR; Pulmonary; Pulmonology; Ql; Qual; Qualitative; Random; Respiratory; Screen; Serology; thoracentesis fluid 2.56 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14609-2 Nuclear Ab PrThr Periton fld Pt Ord     ACTIVE Nuclear Ab [Presence] in Peritoneal fluid   MIN DefinitionDescription                   SERO   14609-2         Both       0 ANA Prt Ql           ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Ascites; Ascitic fluid; Ascitis; Autoantibodies; Autoantibody; NA; Nuc; Ordinal; Peritoneal fluid; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Serology 2.56 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
1461-3 Epinephrine^1H post 300 ug cloNIDine PO MCnc Plas Pt Qn     ACTIVE EPINEPHrine [Mass/volume] in Plasma --1 hour post 300 ug cloNIDine PO   MIN DefinitionDescription     pg/mL             CHAL   1461-3         Observation       0 Epineph 1h p 300 ug CLN PO Plas-mCnc       Y   1 hour; 1.0Hr; 1h p 300 ug CLN PO; 60 min; 60 minutes; 60M; 60min; Adrenalin; Adrenaline; Adreneline; After; Catapres; CHEMISTRY.CHALLENGE TESTING; E; Epi; Epin; Epinep; Epineph; Epinphrine; Eppi; Level; Mass concentration; mcg; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random 2.73 1               pg/mL       0
14610-0 Nuclear Ab PrThr Synv fld Pt Ord     ACTIVE Nuclear Ab [Presence] in Synovial fluid   MIN DefinitionDescription                   SERO   14610-0         Both       0 ANA Snv Ql           ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Joint aspirate; Joint fld; Joint flu; Joint fluid; NA; Nuc; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Rheum; Rheumatology; Screen; Serology; SF; SNV; Syn; Syn fl; Synov; Synovial fluid 2.56 1.0k                     The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. 0
14611-8 Nuclear Ab pattern Imp Ser Pt Nom     ACTIVE Nuclear Ab pattern [Interpretation] in Serum   MIN DefinitionDescription                   SERO   14611-8         Both       0 ANA Pat Ser-Imp           ABS; Aby; ANA; ANA Pat; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; NA; Nominal; Nuc; Point in time; Random; Serology; Serum; SR 2.73 1.0k                       0
14612-6 Nuclear Ab Titr Pericard fld Pt SemiQn     ACTIVE Nuclear Ab [Titer] in Pericardial fluid   MAJ DefinitionDescription     titer             SERO   14612-6         Both       0 ANA Titr Pcar       Y   ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Cardio; Cardiology; Dilution factor; Dilution Factor (Titer); Heart Disease; NA; Nuc; PCAR; Pericardial Fluid; Point in time; Random; Serology; SmQn; Titer; Titered; Titre; Ttr 2.75 1.0k               {titer}       0
14613-4 Nuclear Ab Titr Body fld Pt SemiQn     ACTIVE Nuclear Ab [Titer] in Body fluid   MAJ DefinitionDescription     titer             SERO   14613-4         Both       0 ANA Titr Fld       Y   ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; B/F; BF; bod; Bodies; Body fluid; Body fluid, unsp; Dilution factor; Dilution Factor (Titer); Fl; Fld; FLU; Fluid; NA; Nuc; Point in time; Random; Serology; SmQn; Titer; Titered; Titre; Ttr 2.75 1.0k               {titer}       0
14614-2 Nuclear Ab Titr Plr fld Pt SemiQn     ACTIVE Nuclear Ab [Titer] in Pleural fluid   MAJ DefinitionDescription     titer             SERO   14614-2         Both       0 ANA Titr Plr       Y   ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); Lung; NA; Nuc; Pleural; Pleural fluid; Point in time; Pulmonary; Pulmonology; Random; Respiratory; Serology; SmQn; thoracentesis fluid; Titer; Titered; Titre; Ttr 2.75 1.0k               {titer}       0
14615-9 Nuclear Ab Titr Periton fld Pt SemiQn     ACTIVE Nuclear Ab [Titer] in Peritoneal fluid   MAJ DefinitionDescription     titer             SERO   14615-9         Both       0 ANA Titr Prt       Y   ABS; Aby; ANA; ANF; Antby; Anti; Antibodies; Antibody; Antinuclear antibody; Ascites; Ascitic fluid; Ascitis; Autoantibodies; Autoantibody; Dilution factor; Dilution Factor (Titer); NA; Nuc; Peritoneal fluid; Point in time; Prt; Random; Serology; SmQn; Titer; Titered; Titre; Ttr 2.75 1.0k               {titer}       0
104,672 results found